Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Inada

Showing results (431-440 of 480) with videos related to

Pageof 48
Sort By:
Bioconjugate Chemistry|January 19, 2000
Hydrogen gas evolution and carbon dioxide fixation with visible light by chlorophyllin coupled with polyethylene glycolT Itoh, H Asada, K Tobioka, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)Y Shibouta, Y Inada, M Ojima, et al.
Masui. the Japanese Journal of Anesthesiology|January 1, 1985
[Neuromuscular blocking action and pharmacokinetics of vecuronium bromide in man--a comparison with pancuronium bromide]N Sugai, C Yajima, Y Inada, et al.
Masui. the Japanese Journal of Anesthesiology|October 1, 1994
[Clinical evaluation of controlled hypotensive anesthesia with MR7S1]Y Inada, K Numata, Y Ide, et al.
Kidney International|November 1, 1994
Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injuryS Kim, K Ohta, A Hamaguchi, et al.
Masui. the Japanese Journal of Anesthesiology|April 1, 1986
[Evaluation of neuromuscular blocking and circulatory effects of vecuronium bromide and pancuronium bromide by a double blind study]N Sugai, Y Inada, Y Goto, et al.
Biochemical Pharmacology|July 20, 1993
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistM Noda, Y Shibouta, Y Inada, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive ratsS Kim, K Ohta, A Hamaguchi, et al.
Abdominal Imaging|April 14, 2007
Diffusion-weighed MR imaging of pancreatic carcinomaM Matsuki, Y Inada, G Nakai, et al.
Experimental Cell Research|May 1, 1992
Poly(ADP ribose) polymerase-defective mutant cell clone of mouse L1210 cellsK Yoshihara, A Itaya, T Hironaka, et al.
Pageof 48

Showing results (431-440 of 480) with videos related to

Sort By:
Pageof 48
Bioconjugate Chemistry|January 19, 2000
Hydrogen gas evolution and carbon dioxide fixation with visible light by chlorophyllin coupled with polyethylene glycolT Itoh, H Asada, K Tobioka, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116)Y Shibouta, Y Inada, M Ojima, et al.
Masui. the Japanese Journal of Anesthesiology|January 1, 1985
[Neuromuscular blocking action and pharmacokinetics of vecuronium bromide in man--a comparison with pancuronium bromide]N Sugai, C Yajima, Y Inada, et al.
Masui. the Japanese Journal of Anesthesiology|October 1, 1994
[Clinical evaluation of controlled hypotensive anesthesia with MR7S1]Y Inada, K Numata, Y Ide, et al.
Kidney International|November 1, 1994
Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injuryS Kim, K Ohta, A Hamaguchi, et al.
Masui. the Japanese Journal of Anesthesiology|April 1, 1986
[Evaluation of neuromuscular blocking and circulatory effects of vecuronium bromide and pancuronium bromide by a double blind study]N Sugai, Y Inada, Y Goto, et al.
Biochemical Pharmacology|July 20, 1993
Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonistM Noda, Y Shibouta, Y Inada, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive ratsS Kim, K Ohta, A Hamaguchi, et al.
Abdominal Imaging|April 14, 2007
Diffusion-weighed MR imaging of pancreatic carcinomaM Matsuki, Y Inada, G Nakai, et al.
Experimental Cell Research|May 1, 1992
Poly(ADP ribose) polymerase-defective mutant cell clone of mouse L1210 cellsK Yoshihara, A Itaya, T Hironaka, et al.
Pageof 48